Cargando…

Algorithmic Modeling Quantifies the Complementary Contribution of Metabolic Inhibitions to Gemcitabine Efficacy

Gemcitabine (2,2-difluorodeoxycytidine, dFdC) is a prodrug widely used for treating various carcinomas. Gemcitabine exerts its clinical effect by depleting the deoxyribonucleotide pools, and incorporating its triphosphate metabolite (dFdC-TP) into DNA, thereby inhibiting DNA synthesis. This process...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahramanoğullari, Ozan, Fantaccini, Gianluca, Lecca, Paola, Morpurgo, Daniele, Priami, Corrado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519828/
https://www.ncbi.nlm.nih.gov/pubmed/23239976
http://dx.doi.org/10.1371/journal.pone.0050176

Ejemplares similares